Home

Richard J. Lim

CIK 1623720 · last filed 2019-04-03

Richard J. Lim is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for REPL, was dated Apr 3, 2019. Across all open-market trades the lifetime net is +$6.0M, making them a net buyer over the disclosed history. 10 SEC filings were submitted jointly with Anne-Mari Paster.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

3

Lifetime Open-Market Net

$6.00M

Filer Profile

Reported Address
888 BOYLSTON ST., SUITE 1111
BOSTON, MA 02199
Related Filers
Anne-Mari Paster — 10 joint filings, latest 2019-07-01
Otello Stampacchia — 10 joint filings, latest 2019-07-01
Omega Fund IV G.P. Manager, Ltd. — 7 joint filings, latest 2019-04-03
Omega Fund IV GP, L.P. — 7 joint filings, latest 2019-04-03
Omega Fund IV, L.P. — 7 joint filings, latest 2019-04-03
Claudio Nessi — 5 joint filings, latest 2019-07-01
Omega Fund V GP Manager, Ltd. — 5 joint filings, latest 2019-07-01
Omega Fund V GP, L.P. — 5 joint filings, latest 2019-07-01
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
REPL 10%+ Owner — $15.04 — $0 1 2019-04-03
Paratek Pharmaceuticals, Inc. (PRTK) Delisted Director 779,802 $2.23 $1.74M $6.00M 2 2016-06-29

Recent Filings

3 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-04-03 REPL Grant (A) — $0 EDGAR
2016-06-29 Paratek Pharmaceuticals, Inc. (PRTK) Delisted Buy (P) +461,538 $6.00M EDGAR
2014-11-03 Paratek Pharmaceuticals, Inc. (PRTK) Delisted Other (J) +2,138,872 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.